Originally Aired: June 18, 2020
Time: 8:00 am PT, 11:00 am ET, 17:00 CET

Cell and Gene therapies continue to evolve in their use for treating human diseases. Cell-based therapies are emerging as a promising strategy for cancer, while AAV vectors have taken center stage as a gene delivery vehicle for potential gene therapy for several human diseases.

In this GEN webinar, our expert speakers, who are leading investigators in the field of
cell and gene therapy, will discuss emerging gene-edited and engineered cell therapies for cancer, as well as the next generation of AAV vectors for human gene therapy. Additionally, our speakers will cover some of the following key points:

• Advancements in cell surface receptor-targeted adult stem cells, cancer cells, and T cells expressing novel bi-functional immunomodulatory proteins
• Demonstrate the strength of using innovative gene therapy approaches clinically
• Provide data and rationale for assessing combined cell- and gene-based approaches in preclinical studies

 

A live Q&A session will followed the presentations.

 

Produced with support from:

Perkin Elmer logo

 

 

 

Khalid hah

Khalid Shah, PhD
Vice Chair of Research & Director,
Center for Cellular Therapies
Brigham and Women’s Hospital
Harvard Medical School

Arun Srivastava

Arun Srivastava, PhD
Professor of Genetics
Chief, Division of Cellular
and Molecular Therapy
University of Florida
College of Medicine